REQUEST A DEMO
Total
USD $0.00
Search more companies

Us Pharma Ecza Deposu Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Us Pharma Ecza Deposu Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English Download a sample report

Us Pharma Ecza Deposu Ilac A.S. is a company in Turkiye, with a head office in Istanbul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on December 07, 2018. Us Pharma Ecza Deposu Ilac A.S. currently employs 5 (2023) people. The latest financial highlights indicate a net sales revenue increase of 155.99% in 2021. Its’ total assets recorded a growth of 161.67%. The enterprise’s net profit margin increased by 1.76% in 2021.

Headquarters
No:6 A Soganlik Yeni Mahallesi Behcet Kemal Caglar Sokak Kartal
Istanbul; Marmara; Postal Code: 34880

Contact Details: Purchase the Us Pharma Ecza Deposu Ilac A.S. report to view the information.

Website: http://www.uspharmaecza.com

Basic Information
Total Employees:
Purchase the Us Pharma Ecza Deposu Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Us Pharma Ecza Deposu Ilac A.S. report to view the information.
Incorporation Date:
December 07, 2018
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Us Pharma Ecza Deposu Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
155.99%
Total operating revenue
155.99%
Operating profit (EBIT)
618.44%
Net Profit (Loss) for the Period
512.61%
Total assets
161.67%
Total equity
244.19%
Operating Profit Margin (ROS)
1.7%
Net Profit Margin
1.76%
Return on Equity (ROE)
31.09%
Debt to Equity Ratio
-119.34%
Quick Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?